EligibleTrials

Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease

Recruiting · NCT02447874 · Interventional (participants receive a specific treatment) · Lead sponsor: Emory University

View the official record on ClinicalTrials.gov →
Sickle Cell Disease

Interventions studied

ArginineArginine (Continuous)Arginine (Loading)

What this trial is about

The purpose of this study is to determine whether giving extra arginine to patients with sickle cell disease seeking treatment for vaso-occlusive painful events (VOE) will decrease pain scores, decrease need for pain medications or decrease length of hospital stay or emergency department visit.

Who can take part

Age range
7 Years to 21 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 1, Phase 2
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

2 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.